Regulus Therapeutics: Q1 Earnings Insights

Regulus Therapeutics RGLS reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Regulus Therapeutics reported in-line EPS of $-0.05 versus an estimate of $-0.05.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 5.63% drop in the share price the next day.

To track all earnings releases for Regulus Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.